Amarin Corp plc is a neuroscience company focused on the research, development and commercialisation of novel drugs for the treatment of central nervous system disorders.

I’m still kicking myself for not buying this stock when I had a chance to. A month ago, I added this stock to my “Investment to Watch” List. At that time, the stock was traded at $1.95/share.

And now? It’s $3.32/share!!!

I gotta tell you, it’s really hard to find a cheap biotech stock. But I was pretty lucky finding this one. Had I bought 1,000 shares of it a month ago, I would’ve made $1,370 by now.

In the past few months, a lot of things have happened in the company. They announced $2 million equity investment by Dr. Tony Ryan (who is a Director of Ryanair Holdings and was a founder and former Chairman of GPA Group plc, an operating lessor of commercial aircraft. Dr. Ryan also served as Executive Chairman of GE Capital Aviation Services, Limited), preliminary results from Parkinson’s disease pre-clinical program using Miraxion (studies show that Miraxion has neuroprotective effects in Parkinson’s disease), they licensed Phase IIb/III Drug for the treatment of fatigue in multiple sclerosis to Multicell Inc., and they raised another $24 million in private placement.

Here’s how their price/share has been performing in the past 30 days:

What do you think, huh? This one is definitely a good investment.

As I said before, I’m still kicking myself for not getting this one a month earlier. On the other hand, it’s still not too late to invest your money in this company…

Quote of the Day:
Great investment opportunities come around when excellent companies are surrounded by unusual circumstances that cause the stock to be misappraised. - Warren Buffett